Effect of a multicomponent exercise programme (VIVIFRAIL) on functional capacity in frail community elders with cognitive decline: study protocol for a randomized multicentre control trial by Casas Herrero, Álvaro et al.
STUDY PROTOCOL Open Access
Effect of a multicomponent exercise
programme (VIVIFRAIL) on functional
capacity in frail community elders with
cognitive decline: study protocol for a
randomized multicentre control trial
Alvaro Casas-Herrero1,2,3, Ivan Anton-Rodrigo4,6, Fabricio Zambom-Ferraresi2,3, Mikel L. Sáez de Asteasu2,3,5,
Nicolás Martinez-Velilla1,2,3, Jaione Elexpuru-Estomba4, Itxaso Marin-Epelde1,2, Fernanda Ramon-Espinoza1,2,
Roberto Petidier-Torregrosa7, Juan L. Sanchez-Sanchez7, Berta Ibañez8 and Mikel Izquierdo2,3,5*
Abstract
Background: The benefit of physical exercise in ageing and particularly in frailty has been the aim of recent research.
Moreover, physical activity in the elderly is associated with a decreased risk of mortality, of common chronic illnesses
(i.e. cardiovascular disease or osteoarthritis) and of institutionalization as well as with a delay in functional decline.
Additionally, very recent research has shown that, despite its limitations, physical exercise is associated with a reduced
risk of dementia, Alzheimer disease or mild cognitive decline. Nevertheless, the effect of physical exercise as a
systematic, structured and repetitive type of physical activity, in the reduction of risk of cognitive decline in the elderly,
is not very clear. The purpose of this study aims to examine whether an innovative multicomponent exercise
programme called VIVIFRAIL has benefits for functional and cognitive status among pre-frail/frail patients with mild
cognitive impairment or dementia.
Methods/design: This study is a multicentre randomized clinical trial to be conducted in the outpatient geriatrics
clinics of three tertiary hospitals in Spain. Altogether, 240 patients aged 75 years or older being capable of and willing
to provide informed consent, with a Barthel Index ≥ 60 and mild cognitive impairment or mild dementia, pre-frail or
frail and having someone to help to supervise them when conducting the exercises will be randomly assigned to the
intervention or control group. Participants randomly assigned to the usual care group will receive normal outpatient
care, including physical rehabilitation when needed. The VIVIFRAIL multicomponent exercise intervention programme
consists of resistance training, gait re-training and balance training, which appear to be the best strategy for improving
gait, balance and strength, as well as reducing the rate of falls in older individuals and consequently maintaining their
functional capacity during ageing.
The primary endpoint is the change in functional capacity, assessed with the Short Physical Performance Battery (1 point
as clinically significant). Secondary endpoints are changes in cognitive and mood status, quality of life (EQ-5D), 6-m gait
velocity and changes in gait parameters (i.e. gait velocity and gait variability) while performing a dual-task test (verbal and
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counting), handgrip, maximal strength and power of the lower limbs as well as Barthel Index of independence (5 points
as clinically significant) at baseline and at the 1-month and 3-month follow-up.
Discussion: Frailty and cognitive impairment are two very common geriatric syndromes in elderly patients and are
frequently related and overlapped. Functional decline and disability are major adverse outcomes of these conditions.
Exercise is a potential intervention for both syndromes. If our hypothesis is correct, the relevance of this project is that the
results can contribute to understanding that an individualized multicomponent exercise programme (VIVIFRAIL) for frail
elderly patients with cognitive impairment is more effective in reducing functional and cognitive impairment than
conventional care. Moreover, our study may be able to show that an innovative individualized multicomponent exercise
prescription for these high-risk populations is plausible, having at least similar therapeutic effects to other pharmacological
and medical prescriptions.
Trial registration: ClinicalTrials.gov, NCT03657940. Registered on 5 September 2018.
Keywords: Multicomponent exercise, Frail, Gait impairment, Functional capacity, Cognitive impairment
Background
The progressive ageing of the population and the chal-
lenges surrounding the care of elderly people have
become an emergency for all health systems. The aged
population has resulted in an increase in the activity of
health and social services, and the needs of this popula-
tion are completely different compared to those of
similar age groups 50 years ago. Nowadays, it is time for
a clinical transition in health systems, moving from
disease management to a more functional perspective,
around the principles of integrated, coordinated, contin-
ued and patient-centred care [1]. In this context, the
World Health Organization recently stated that health-
related policies should be considered from the perspec-
tive of the elderly person’s functional capacity (intrinsic
capacity) rather than the disease or comorbidity experi-
enced at a single point in time [2].
Frailty is a clinical syndrome defined by vulnerability
and an increased risk of the individual to develop nega-
tive health-related events as disability and/or mortality
under external stressors factors [3]. The frail phenotype
pays attention to five domains (nutritional status, energy,
physical activity, mobility and strength), and five criteria
have been stablished (one per each domain: weight loss, ex-
haustion, leisure-time activity, gait speed and grip strength,
respectively) [4] to identify older persons at high risk of nu-
merous adverse outcomes [5, 6]. Some cross-sectional stud-
ies show the relation between frailty, mild cognitive
impairment (MCI) and dementia, but the longitudinal rela-
tion is uncertain. Probably, the relation between cognitive
impairment and frailty [7] in some cases is strong and bidir-
ectional, since they share common pathophysiological bases
and the same outcomes as hospitalization, falls, fractures,
disability, institutionalization and mortality. Recently, the
frailty Toledo study of aging has showed that cognitive im-
pairment and muscular strength have a direct proportional
relationship [8]. Therefore, dementia shares part of the
same characteristics that can be found in the frail pheno-
type like subtle gait impairments (slow gait velocity and in-
crease gait variability) and poor physical activity (Fig. 1).
The regular practice of physical exercise constitutes an
inexpensive and healthy way of preventing and treating
several illnesses related to the cardiovascular system and
a sedentary lifestyle. Physical exercise programmes have
been shown to be a novel “prescription tool” to prevent
or delay the appearance of disability [9], to diminish
healthcare costs [10] and to delay premature mortality
[11, 12]. In the context of the ageing population, the
performance of physical exercise can be considered the
most effective intervention to delay disability and ad-
verse events that are usually associated with frailty and
vulnerable ageing. In some studies, exercise has shown
even more positive results in terms of mortality from
different diseases and chronic conditions than poly-pills
for cardiovascular prevention [13]. Physical exercise, as
an individual intervention, is one of the most important
components in improving the functional capacity of frail
seniors, and muscle strengthening in particular should
be at the forefront of the treatment [14].
The benefit of physical exercise in ageing and particu-
larly in frailty has been the aim of recent research.
Moreover, physical activity in the elderly is associated
with a decreased risk of mortality, of common chronic
illnesses (i.e. cardiovascular disease or osteoarthritis) and
of institutionalization as well as with a delay in func-
tional decline. Additionally, very recent research has
shown that, despite its limitations, physical exercise is
associated with a reduced risk of dementia, Alzheimer
disease or mild cognitive decline [15, 16]. Nevertheless,
the effect of physical exercise as a systematic, structured
and repetitive type of physical activity, in the reduction
of risk of cognitive decline in the elderly, is not very
clear. In this context, the most beneficial type of physical
exercise is called multicomponent exercise [17–20]. This
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type of programme combines strength, resistance (aer-
obic), balance and flexibility training and has been
shown to result in great improvements in functional
capacity, which is a key point in maintaining independ-
ence in instrumental and basic activities of daily living.
Considering the relation between frailty and cognition
previously mentioned (Fig. 1), it makes sense that those
interventions proved to be effective in frail elderly people
could be also effective in the elderly with cognitive impair-
ment, and vice versa. Although there are still few studies,
some of them show how resistance exercise programmes
during 12 weeks in older adults not only induce improve-
ments in gait velocity but also improvements in executive
functions [21] which are directly related to fall risk [22].
Additionally, recent research [23] has shown that, despite
its limitations, multicomponent exercise can be one of the
best approaches to improving functional capacity and ex-
ecutive functions and to decreasing fall risk and cognition
in frail institutionalized elderly with cognitive impairment
and dementia [22]. Other authors have found similar re-
sults in terms of reversing the frailty status and cognitive
improvements in community-dwelling elderly without
basal cognitive impairment [24].
In this context, the purpose of this study aims to
examine whether an innovative multicomponent exer-
cise programme called VIVIFRAIL [25–27] has bene-
fits for functional and cognitive status among pre-
frail/frail patients with MCI or dementia. VIVIFRAIL
was developed by world experts in the field of phys-
ical exercise and frailty, and is considered an import-
ant step towards the novel era of precise prescription
of physical activity [26, 27]. Recently, it has been
proven safe and effective to reverse the functional de-
cline associated with acute hospitalization in very old
patients [28]. This programme is a significant step
towards an individualized physical exercise programme [27]
according to the functional capacity of each elderly person
and includes specific recommendations on doses (intensity,
volume and frequency), similar to other treatments applied
to vulnerable populations, such as frail elderly individuals
with cognitive complaints.
Methods
Study design and setting
This study is a multicentre randomized clinical trial
to be conducted in the outpatient geriatrics clinics of
three tertiary hospitals in Spain. Geriatric clinics are
part of routine geriatric clinical work and normally
patients come from primary care or other specialities.
Patients who meet the inclusion criteria will be ran-
domly assigned to the intervention or control group.
Prior to randomization, the attending geriatrician will
review the absolute and relative contraindications to
participate in the exercise programme and will pro-
vide general information about the study. Patient re-
cruitment will begin with the normal visit of the
patient to the clinic assessing for inclusion criteria
and obtaining informed consent. Later on, subjects
will be randomly assigned (as explained in the follow-
ing) to either the intervention or the control group.
The researcher who decides whether the patient is
assigned to the intervention or control group will not
be the attending geriatrician. Patients or their rela-
tives (if the patient has dementia) will be informed of
the random inclusion in one group but will not be in-
formed regarding to which group they belong. The
data for both the intervention group and the control
group will be obtained at three different times: at
baseline and at the 1-month and 3-month follow-up.
We will perform two telephone calls (15 days and 2
Fig. 1 Proposed relation, sharing mechanisms and similar outcomes between frailty, mild cognitive impairment (MCI) and dementia
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months after baseline) to assess adherence and
reinforce the protocol applied. In addition, in order
to improve the adherence of the exercise programme,
participants in the intervention group will record a
diary that will be reviewed during follow-up. After
randomization, the research team (physiotherapist,
sport science specialist and geriatrician) will together
perform the baseline measurement and follow-up
visits of functional, pharmacological, comorbidity and
cognitive assessment, as well as of mobility and
strength evaluations (Table 1). The multidisciplinary
research team have well-known previous experience
in functional geriatric assessment and in the prescrip-
tion of exercise in frail aged participants in different
clinical settings [25, 26, 28].
Basic sociodemographic data of the participants will
be collected in the baseline visit. All adverse events, in-
cluding those related to exercise such as muscle pain, fa-
tigue and general aches and pains, will be recorded in an
“adverse events diary” during follow-up visits and tele-
phone calls by the training and testing staff, and by self-
report during the study period. The study flow diagram
is shown in Fig. 2. The time at which different variables
(primary and secondary) will be measured is presented
in Table 1. The protocol employs relevant standard
protocol items for clinical trials according to the SPIRIT
2013 statement (Additional file 1) [29] and follows the
CONSORT statement [30] for transparent reporting.
The trial is registered at ClinicalTrials.gov (identifier
number iNCT03657940), and the status is recruitment.
Table 1 Schedule for the different primary and secondary variables for the participants of the study
Measure Screening T1
Baseline
T2
1 month
T3
3 months
Primary outcome
Short Physical Performance Battery (SPPB) X X X
Secondary outcomes
Barthel Index X X X
Frailty according to the Fried criteria X
Montreal Cognitive Assessment (MOCA)—only for
mild cognitive impairment
X X X
Categorical scale of pain X X
Geriatric Depression Scale of Savage (GDS) X X
Minimental Cognitive Exam (MEC-Lobo) X X X
Gait velocity test (GVT) X X X
Dual task (verbal and counting GVT) X X X
Maximal isometric force of handgrip, knee extension
and hip flexion
X X X
Isaacs Set Test X X
Quality of Life (EQ-5D) X X
Trail Making Test (TMT—Part A) X X X
1RM (leg press) X X X
Muscle power at 50% 1RM in leg press X X X
Drugs, geriatric syndromes and psycho-behavioural symptoms X X
Cumulative Illness Rating Scale for Geriatrics (CIRS-G) X
Functional Activities Questionnaire (FAQ) X X X
Mini Nutritional Assessment (MNA) X
Acceleration data: gait kinematic parameters (regularity,
variability, cadence), Five Times Sit to Stand Test (peak power,
impulse) and balance parameters (power spectrum, area)
X X X
Rate and risk of falls X X X
Mortality X X X
Admission and readmission to hospital X X X
Institutionalization X X X
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Study participants and eligibility criteria
The study will include outpatients of the Geriatrics
Department of the Complejo Hospitalario of Navarra,
the Matia Foundazioa in San Sebastian and the Hospital
of Getafe (all three in Spain) older than 75 years of age
between September 2017 and May 2019. Inclusion
criteria include patients aged 75 years or older being
capable and willing to provide informed consent, able to
communicate and ambulate with or without personal/
technical assistance, with a Barthel Index ≥ 60 and MCI
or mild dementia according to DSM V criteria [31], level
GDS-4 (Reisberg classification) [32], pre-frail or frail ac-
cording to the Fried criteria [4] and having someone to
help to supervise them when conducting the exercises.
The exclusion criteria include having any factor that
precludes the performance of the physical training
programme or testing procedures as determined by the
attending physician. These factors, according to the
VIVIFRAIL programme [26] include, but are not limited
to, the following:
– myocardial infarction in the past 3 months;
– unstable angina pectoris;
– terminal illness;
– uncontrolled arrhythmia;
– unstable cardiovascular disease or other unstable
medical condition;
– uncontrolled arterial hypertension;
– recent pulmonary thromboembolism;
– upper or lower extremity fracture in the past 3
months;
– institutionalized or pending entry into institution;
and
– unwillingness to either complete the study
requirements or to be randomized into the control
or the intervention group.
Randomization and blinding
Participants in the study will be randomized (www.ran-
domizer.org) into an intervention group and a usual care
group (control group) following a simple randomization
procedure, in a 1:1 ratio without restriction. Participants
will be explicitly informed and reminded not to discuss
their randomization assignment with the assessment
Fig. 2 Flow diagram of the study protocol
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staff. The assessment staff will be blinded to the partici-
pants’ groups as well as to the main study design and to
what changes in study outcomes we expect to occur in
either group.
It will not be possible to conceal the group assignment
from the staff involved in the training of the intervention
group. Patients (or their families) will be informed of
their random inclusion in one group but will not be in-
formed regarding to which group they belong.
Statistics and sample size
Assuming an alpha error of α = 5%, a correlation be-
tween pre and post-intervention values of the Short
Physical Performance Battery (SPPB) of ρ = 0.5 and a
standard deviation for the SPPB of σ = 2.5, the required
sample size to have a power of 90% to detect a minimum
difference of 1 point between groups in the post–pre
SPPB score is 101 patients per group. Taking into
account an expected loss of patients along the follow-up
of 15%, the final sample size required is 120 per group.
For the estimation, an ANCOVA method for the analysis
of the differences has been considered. The research
team will be focused to instruct and remind geriatricians
periodically to assess inclusion and exclusion criteria in
all three centres in order to reach target sample size. All
of the centres have a remarkable clinical activity attend-
ing around 1000 patients every year. It is expected than
15% of these patients in every centre can be potentially
eligible participants. In the unlikely case of not reaching
the expected sample size, we will extend the inclusion
period for a further 3 months.
The description of the sample by group will be con-
ducted using statistics such as means and standard devi-
ations or medians and interquartile ranges for the
quantitative variables, and frequencies and percentages
for the qualitative variables. For comparisons between
groups at baseline, t tests or Mann–Whitney U tests will
be used for continuous variables, depending on normal-
ity, which will be checked for each using the Kolmogo-
rov–Smirnov test and normal probability plots, and the
chi-square test or Fisher’s test will be used for categor-
ical variables. To determine the efficacy of the interven-
tion in the quantitative variables, such as the SPPB, we
will use ANCOVA models, using post-intervention
values as dependent variables, group study as the princi-
pal effect and pre-intervention values as covariates. In
the case of qualitative or categorized variables (such as
whether an improvement of a given magnitude between
pre and post intervention has been achieved or not),
comparisons between groups will be conducted with the
chi-square test or Fisher’s test, and complemented with
logistic regression if additional adjustment is needed.
The level of statistical significance will be 0.05. Data will
be analysed using an intention-to-treat approach with R
and SPSS statistical packages.
We will adopt a complete case analysis as the primary
analysis if the proportions of missing data are equal to
or below 5% and it is implausible that certain patient
groups specifically are lost to follow-up in one of the
compared groups. To check the assumption that the po-
tential impact of missing data is negligible (created by a
missing complete at random or a missing not at random
mechanism), best–worst and worst–best case sensitivity
analyses will be used. When the proportions of missing
data are above 5% and if this is supported by the previ-
ous sensitivity analysis, a missing at random mechanism
will be assumed and missing values will be imputed
using the R package MICE (Multivariate Imputation via
Chained Equations). If the proportions of missing data
are very large (more than 40%) on important variables,
then trial results will be considered as hypothesis-
generating results.
Data management
Completed personal data or other documents containing
protected personal health information will be kept in a
locked file at the principal investigator office in every
centre. Data will be entered into an electronic de-identified
database by authorized study team members, and checked
for completeness and accuracy. Access to data with identi-
fiers will be restricted to authorized study team members
and authorities. Electronic data will be stored on a secure
server regulated by the local research institute (IDISNA).
Identifiable data will be destroyed 10 years after study
finalization or 5 years after last publication.
Detailed description of the intervention
Participants will be randomly assigned to the following
groups.
Usual care group (control)
Participants randomly assigned to the usual care group
will receive normal outpatient care, including physical
rehabilitation when needed.
Multicomponent VIVIFRAL exercise group
The multicomponent physical exercise programme will be
the VIVIFRAIL programme which was developed in
Europe (Erasmus+ programme of the European Union).
The VIVIFRAIL [26, 27] multicomponent exercise inter-
vention programme consists of resistance training, gait re-
training and balance training, which appear to be the best
strategy for improving gait, balance and strength, as well
as reducing the rate of falls in older individuals and conse-
quently maintaining their functional capacity during
ageing [26, 27]. This type of intervention has also been
proven as the most effective to delay disability, cognitive
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impairment and depression [33] as well as effective to
reverse the functional decline associated with acute
hospitalization in very old patients [28].
The VIVIFRAIL exercise programme offers a general
guideline to design a multicomponent physical exercise
programme for frailty and falls treatment and prevention
among people aged older than 70 years [26]. The
programme is personalized, depending on the older per-
son’s functional capacity level (serious limitation, moder-
ate limitation and slight limitation as evaluated by the
SPPB and a walking speed test) and the risk of falling.
VIVIFRAIL works on the following components of phys-
ical fitness: arm and leg strength and power, balance and
coordination to prevent falls, flexibility and cardiovascu-
lar endurance (i.e. walking).
All of the exercises outline the procedure, guidelines
for starting, frequency and progression to be able to cor-
rectly monitor the instructions prescribed to the patient
and improve their health [26].
To individualize the exercise programme we will assess
the initial functional capacity and determine the risk of
falling. Different functional capacity levels will be deter-
mined based on the scores obtained from the Short Phys-
ical Performance Battery Test (SPPB) and the 6-m gait
velocity test (GVT) (see Fig. 3), with each leading to the
recommendation of a certain customized multi-
component physical exercise programme (Program A, B,
C1, C2 or D) (see Fig. 3). Two sub-types will be defined in
order to more accurately recommend a particular cardio-
vascular endurance programme for the group with slight
limitation (frail/pre-frail) based on the maximum time
they can walk without help. If the person can walk for 10–
30min, they are known as C1; and if they can walk for
30–45min, they are known as C2 [26].
This classification will be complemented according to
the risk of falling, assessed by the answer to some simple
questions (see Fig. 3). If a risk for falling is detected, the
frequency of the exercise will be increased and some add-
itional measures will be adopted, as depicted in the lower
part of the right-hand side of Fig. 3. Finally, the participant
will be assessed for potential contraindications or need of
medical evaluation (left-hand side of Fig. 3) [26].
Fig. 3 Classification by allocation of the participant to a physical exercise group by the SPPB, gait speed and risk of falls. Modified from Izquierdo
et al. [26]
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Once the patient has been assigned to one of the six
categories, a multicomponent programme taking 12
weeks will be implemented. The general characteristics
of the different programmes are shown in Fig. 4.
Resistance training
 Sets and repetitions:
The session should begin by performing two
sets of 10 repetitions (i.e. 10 repetitions of the
selected movements).
The goal is to perform three sets of 12
repetitions.
A 1-min to 3-min break should be taken
between exercises.
The exercises should be performed on 3 days
per week.
 Intensity and progression:
For weight exercises, a weight or resistance
band should be chosen that will allow the patient
to perform the exercise without interruptions at
least 30 times but with a certain degree of effort to
complete the activity. The first step will be to
determine the exercise or weight that allows them
to do the exercise properly about 30 times without
stopping yet makes them feel as though they have
made an effort by the end.
To be effective, this programme should be
followed for 12 weeks. After that time, the tests
(the SPPB, GVT and assessment for determining
risk of falls) should be repeated.
 Strength and power exercises are shown in
Izquierdo et al. [26].
Cardiovascular training
 Sets and repetitions:
When the elderly person improves their
muscular strength, the cardiovascular exercise
programme shall begin.
Walk, alone or with help at usual walking pace,
until you are able to walk for 1 min without help.
For example:
▪ Walk 5–10 s, rest 10 s.
▪ Repeat five to seven times.
Fig. 4 Classification by allocation and examples of exercises of the participant according to a functional level group by the SPPB, gait speed and
risk of falls. Modified from Izquierdo et al. [26]
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▪ +
▪ Walk 10–15 s, rest 20 s.
▪ Repeat five to seven times.
Begin by walking for 4 min until you are able
to walk for 15 min.
Begin by walking for 8 min until you are able
to walk for 30 min.
Walk in sets of 15 min each, resting for 30 s
between sets.
 Cardiovascular protocol and exercises in detail
according to function are shown in Izquierdo et
al. [26].
Balance training
 Sets and repetitions:
Remain in the same position and count to 10
(progress up to 30) with each leg. Rest no less
than 1 min and no more than 3 min. Repeat with
each leg.
+
Walk one set of 10 steps. Stop and rest for 10 s
without sitting. Rest no less than 1 min and no
more than 3 min. Repeat.
+
Walk in a relaxed way and step over the
obstacles. Set up five obstacles to begin. When you
finish the walk, begin again. Repeat eight times.
 Intensity and progression:
Change the position of your arms; cross your
arms or make a cross shape, for example.
Do the exercises on different surfaces; on a rug,
for example.
Close your eyes, but only if someone is near to
help you.
 Balance exercises are shown in Izquierdo et al. [26].
Flexibility
 Sets and repetitions:
Two sets of three repetitions (remain in the
same position for 10 s).
 Intensity and progression:
Stretch until you feel a bit of tension and then
remain in the same position for 10–12 s.
Stretch without creating any excessive
muscular elongation or articular tension.
Every day.
After the muscular strength and power or
cardiovascular exercises.
 Flexibility exercises are shown in Izquierdo et al. [26].
Materials will be also provided to the caregivers and
the participants in the Spanish language. All of the mate-
rials to be used will be properly adapted to the focused
population. This exercise programme has recently
launched the Vivifrail App for IOS and Android operat-
ing systems, which enables health professionals to assess
the functional ability of elderly subjects and help them
to prescribe a tailored multi-component physical exer-
cise programme [26, 27] (www.vivifrail.com).
Outcome measures
Primary outcome
The primary outcome measure is the change in func-
tional and cognitive status during the study period. The
functional capacity of patients will be evaluated by the
Short Physical Performance Battery (SPPB) [34], which
evaluates, balance, gait ability and leg strength using a
single tool. The total score ranges from 0 (worst) to 12
points (best). The SSPB test has been shown to be a
valid instrument for screening frailty and predicting
disability, institutionalization and mortality. A total score
of less than 10 indicates frailty and a high risk of disabil-
ity and falls. A 1-point change in the score has clinical
relevance [35, 36].
Secondary outcomes
Loss of handgrip in the dominant hand is a useful tool
for the measurement of functional capacity. This charac-
teristic is a strong predictor of disability, morbidity and
mortality as well as one of the components of Fried’s
frailty phenotype [4]. Furthermore, the functional status
of patients will also be assessed at recruitment with the
Barthel Index [37], an international and validated tool of
disability. The score ranges from 0 (severe functional de-
pendence) to 100 (functional independence). At baseline,
gait ability will be assessed using the 6-m gait velocity
test (GVT). Starting and ending limits will be marked on
the floor with tapelines for a total distance of 8 m. Par-
ticipants will be instructed to walk at their self-selected
usual pace for two attempts. The best result of both tri-
als will be registered. The first and last metre, consid-
ered the warm-up and deceleration phases, respectively,
will not be included in calculations of the gait assess-
ment. Dual-task conditions (gait evaluation during the
simultaneous performance of a cognitive task) have re-
cently been recognized as a sensitive assessment method
for interactions among cognition, gait, falls and frailty.
Changes in gait parameters (i.e. gait velocity and gait
variability) while performing a dual-task test (dual-task
cost) may be early predictors of fall risk [38, 39] and
may be useful tools for functional evaluations in frail
older patients. Exercise can modify the dual-task cost
and, consequently, the fall risk and functional capacity
[40]. The dual-task paradigm [37] will be used in the 6-
m habitual GVT. Two trials will be conducted to assess
gait velocity while the patient is performing a verbal or
counting task (verbal GVT and arithmetic GVT, respect-
ively). During the verbal dual-task condition (verbal
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GVT), we will measure gait velocity while participants
are naming animals aloud. During the arithmetic dual-
task condition (arithmetic GVT), we will assess gait vel-
ocity while participants are counting backwards aloud
from 100 in ones. The cognitive score will be measured
by counting the number of animals named (dual-task
with verbal performance) or determining how many
numbers were counted backwards (dual-task with arith-
metic performance). Isometric upper limb (dominant
hand grip) and lower limb (right knee extensors and hip
flexors) muscle strength will be measured using a man-
ual dynamometer. Maximal dynamic strength will be
assessed using the 1RM test in the bilateral leg press
exercise using exercise machines (Matrix, Johnson
Health Tech, Ibérica, S.L., Torrejón de Ardoz, Spain; and
Exercycle S.L., BH Group, Vitoria, Spain). In the first as-
sessment, the subjects will warm up with specific move-
ments for the exercise test. Each subject’s maximal load
will be determined in no more than five attempts, with a
3-min recovery period between attempts. After the 1RM
values are determined, the subjects will perform 10 repe-
titions at maximal velocity and at intensities of 50% of
1RM to determine the maximum power (W) and the
loss of power during the 10 repetitions in the leg press
exercise [41]. The power will be recorded by connecting a
velocity transducer to the weight plates (T-Force System,
Ergotech, Murcia, Spain). During all neuromuscular per-
formance tests, strong verbal encouragement will be given
to each subject to motivate them to perform each test ac-
tion as optimally and rapidly as possible. Distribution of
the training sessions throughout the day should minimize
cumulative fatigue and help to maintain adherence.
Adherence to the exercise programme will be documented
in an individual daily log of the sessions. Changes in
cognitive-affective status after the intervention will be
measured using the Spanish validated versions of the
Minimental Cognitive Exam (MEC-Lobo) [42] in the case
of dementia and the MOCA [43] in the case of MCI. The
Yesavage GDS [44] and Trail Making part A [45] will be
performed to assess depression and executive dysfunction.
During functional tasks (such as balance, gait and rising
from a chair) and cognitive evaluations (dual tasking), an
inertial sensor unit (IU) will be attached over the lumbar
spine (L3) to record the acceleration data in control and
intervention participants [46, 47]. Primary and secondary
variables are presented in Table 1.
Discussion
Frailty and cognitive impairment are two very common
geriatric syndromes in elderly patients and are frequently
related and overlapped. Functional decline and disability
are major adverse outcomes of these conditions. Exercise
is a potential intervention for both syndromes. If our
hypothesis is correct, the relevance of this project is
that the results can contribute to understanding that
the individualized multicomponent exercise programme
(VIVIFRAIL) for frail elderly patients with cognitive
impairment is more effective in reducing functional
and cognitive impairment than conventional care.
Moreover, our study may be able to show that an
innovative individualized multicomponent exercise pre-
scription for these high-risk populations is plausible,
having at least similar therapeutic effects to other
pharmacological and medical prescriptions.
Traditionally, health systems and policies focus atten-
tion on the management of chronic conditions as the
central paradigm of care for the elderly. On the other
hand, evidence coming from a geriatrics perspective in
the last 30 years and international health organizations
such as the World Health Organization (WHO) has
emphasized the significance of maintaining functional
capacity, recently renamed as intrinsic capacity, as the
central objective and focus of all health systems and pol-
icies for elderly populations. Thus, this trial is in line
with these objectives and recommendations. The per-
formance of exercise programmes can improve quality
of life and maintain independence in activities of daily
living, and can potentially improve cognitive function
and prevent adverse health outcomes (i.e. falls and frac-
tures, hospitalizations and nursing homes admissions) in
this high-risk population. In addition, the clinical impact
of this trial can be significant if we help to modify and
shift the traditional management of this population from
an illness model to a more person-centred and function-
ally oriented perspective. Moreover, if our hypotheses
are correct, the prescription of individualized exercise
can be routinely included in the clinical practice of
health professionals tending to elderly frail patients with
cognitive complaints.
An important aspect of our trial is the inclusion of eld-
erly patients with mild cognitive decline and dementia.
So far, the majority of trials in aged frail participants
with these conditions have been routinely excluded. The
inclusion of participants with cognitive impairment in
addition to frailty makes the trial novel and unique with
notable external validity compared with other previous
trials in assessing the effect of individualized exercise
programmes on functional capacity, activities of daily
living and cognitive function.
Another remarkable characteristic of our study is the
utilization of an interdisciplinary team (geriatricians,
nurses, physiotherapy, engineers) that manages not only
the clinical aspects but also the physiotherapy and engin-
eering kinematics. This aspect enables the translation and
application of our results to different clinical practices and
enables the establishment of new protocols related to the
ageing process for different health professionals and for
monitoring functional changes objectively.
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To date, randomized clinical trials with exercise inter-
ventions in aged participants have been heterogeneous
(sometimes with confusing details related to the exercise
programme). An innovative aspect of our trial is the per-
formance of a detailed and well-designed exercise inter-
vention using the VIVIFRAIL methodology that can be
easily extrapolated to other clinical settings and scenar-
ios like community centres, day care centres, nursing
homes and hospitals. If our results confirm our hypoth-
esis, this randomized clinical trial could help to dissem-
inate the “VIVIFRAIL exercise recipe” worldwide to frail
seniors with cognitive decline.
Dissemination
We will disseminate the results of our study via presen-
tations at international conferences and articles in peer-
reviewed journals. The study will be implemented and
reported in accordance with the Standard Protocol
Items: Recommendations for Interventional Trials
(SPIRIT) guidelines.
Future directions
In the near future, this project offers the opportunity
to test and disseminate “in real life” a novel prescrip-
tion exercise tool (VIVIFRAIL) in the very vulnerable
population of frail elders with cognitive decline. The
project will yield direct information about the effects
of a specific and individualized designed exercise
programme in those geriatric conditions. In the long
term, we expect this trial can help to shift actual med-
ical care from the traditional disease perspective to a
more functional management. Another important ex-
pected result in our project is to generalize the pre-
scription of exercise in this population in order to
prevent disability. Finally, with the actual target of a
novel era of precision medicine, our results could be a
significant step forwards to move towards a “precise
prescription of exercise recipe” for older patients with
frailty and cognitive decline impairment.
Trial status
The trial commenced recruitment in September 2017 and
is currently open for recruitment. Recruitment will cease
when 240 participants have been randomized. It is antici-
pated that this target will be reached by September 2019.
Additional file
Additional file 1: SPIRIT 2013 Checklist: Recommended items to address
in a clinical trial protocol and related documents (PDF 68 kb)
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